For patients with moderate-to-severe plaque psoriasis, ixekizumab is effective and safe, with induction therapy enhancing ...

Discover a study where patients initially receiving placebo experienced notable improvement after switching to tildrakizumab.

La La Anthony is partnering with Amgen to raise awareness and support those struggling with plaque psoriasis. The ...

Even though he suffers from psoriasis, Joel Thomas considers himself a lucky man. Psoriasis is a chronic skin disorder that affects over seven and a half million Americans. Many are not as lucky ...

Vyne Therapeutics has dosed the first participant in a Phase Ib trial of VYN202, an oral treatment for moderate-to-severe ...

Dermatologists are practicing in an “era of good efficacy” of nonsteroidal topical therapies for psoriasis, and they can help patients access newer topical medications by working with pharmacies that ...

Despite these limitations, the researchers believe the study confirmed the efficacy and safety of bimekizumab and brodalumab ...

Many people with GPP also have plaque psoriasis and other co-occurring conditions such as psoriatic arthritis. GPP is treatable, and treatment depends on the severity of the condition. Topical ...

Super Bowl LIX champion Dallas Goedert of the Philadelphia Eagles shares his journey with plaque psoriasis. After 20 years of living with the autoimmune skin condition, Goedert is spreading awareness ...

YESINTEK is approved for Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis, offering a ...

Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasisTop-line data from the 12-week double-blind ...